MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01748721
Recruitment Status : Completed
First Posted : December 12, 2012
Last Update Posted : January 8, 2016
National Cancer Institute (NCI)
Children's Oncology Group
Information provided by (Responsible Party):

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : May 2015
  Actual Study Completion Date : May 2015